+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global In-Vitro Diagnostics Instruments Market (2021-2026) by Instruments, Technology, Application, End-Users, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 203 Pages
  • June 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5410387
The Global In-Vitro Diagnostics Instruments Market is estimated to be USD 22.34 Bn in 2021 and is expected to reach USD 32.7 Bn by 2026, growing at a CAGR of 7.92%.



Market Dynamics

The factors contributing towards the growth of the In-vitro diagnostics instruments market are the increasing prevalence of chronic and infectious diseases, rising geriatric population, awareness growing for self-testing, and personalized medicines. The increasing product launches with automated instruments and equipment in laboratories and growing awareness of Point-of-care testing have further escalated the market growth. The global in-vitro diagnostic instrument market may hinder due to the unfavorable reimbursement policy and high cost of devices.
The development of condition-specific markers and tests and the paradigm shift from traditional diagnostics to a new generation of diagnostics are anticipated to create opportunities for the emerging markets.

Market Segmentation

The Global In-Vitro Diagnostics Instruments Market is segmented further based on Instruments, Technology, Application, End-Users, and Geography.

By Instruments, the market is classified into Fully-Automated Instruments, Semi-Automated Instruments, And Others. Amongst all, the Fully-Automated Instruments segment is estimated to hold the highest market share during the forecast period.

By Technology, the market is classified as Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis, Other Technologies, and Others. Amongst all, the Immunoassay/Immunochemistry segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as Infectious Diseases, Diabetes, Oncology, Cardiology, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Nephrology, and Others. Amongst all, the Infectious Diseases segment is estimated to hold the highest market share during the forecast period.

By End-User, the market is classified as Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing, Self-Testing, Academic Institutes, and Others. Amongst all, the Hospital Laboratories segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Abbott Launches Panbio™ COVID-19 Antigen Self-Test in India - 12th July 2021
2. Thermo Fisher Scientific launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use - 25st March 2021

Company Profiles

Some of the companies covered in this report are Abbott Laboratories, bioMérieux, Illumina, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Sysmex Corporation, Fisher Scientific International, Becton, Dickinson and Company, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global In-Vitro Diagnostics Instruments Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global In-Vitro Diagnostics Instruments Market

What is the estimated value of the Global In-Vitro Diagnostics Instruments Market?

The Global In-Vitro Diagnostics Instruments Market was estimated to be valued at $22340 Million in 2021.

What is the growth rate of the Global In-Vitro Diagnostics Instruments Market?

The growth rate of the Global In-Vitro Diagnostics Instruments Market is 7.9%, with an estimated value of $32700 Million by 2026.

What is the forecasted size of the Global In-Vitro Diagnostics Instruments Market?

The Global In-Vitro Diagnostics Instruments Market is estimated to be worth $32700 Million by 2026.

Who are the key companies in the Global In-Vitro Diagnostics Instruments Market?

Key companies in the Global In-Vitro Diagnostics Instruments Market include Abbott Laboratories, bioMérieux, Illumina, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Sysmex Corporation and Becton, Dickinson and Company.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Chronic and Infectious Diseases
4.1.2 Rising Elderly Population
4.1.3 Awareness for Self-Testing and Early Disease Diagnosis
4.1.4 Adoption of Automated Instruments
4.1.5 Increase In Point-Of-Care Testing Facilities
4.2 Restraints
4.2.1 Stringent Government Regulations
4.2.2 High Cost of Devices and Unfavorable Reimbursement Policies
4.3 Opportunities
4.3.1 Growing Research on Condition Specific Marker and Testing
4.3.2 Emerging Markets to Offer High-Growth Opportunities for Market Players
4.4 Challenges
4.4.1 Technical Complexities Faced in Conducting Diagnostic Tests
4.5 Trends
4.5.1 Rapid Launch of Diagnostic Kits for the Diagnosis of COVID-19
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global In-Vitro Diagnostics Instruments Market, By Instruments
6.1 Introduction
6.2 Semi-Automated Instruments
6.3 Fully-Automated Instruments
6.4 Others (Accessories, Specimen Collection)
7 Global In-Vitro Diagnostics Instruments Market, By Technology
7.1 Introduction
7.2 Immunoassay/Immunochemistry
7.2.1 Enzyme-Linked Immunosorbent Assays (ELISA)
7.2.1.1 Chemiluminescence immunoassays
7.2.1.2 Fluorescence immunoassays
7.2.1.3 Colorimetric immunoassays
7.2.2 Radioimmunoassays
7.2.3 Rapid Tests
7.2.4 Western Blotting
7.2.5 Enzyme-Linked Immunospot Assays
7.3 Clinical Chemistry
7.3.1 Basic Metabolic Panels
7.3.2 Liver Panels
7.3.3 Renal Profiles
7.3.4 Lipid Profiles
7.3.5 Thyroid Function Panels
7.3.6 Electrolyte Panels
7.3.7 Specialty Chemical Tests
7.4 Molecular Diagnostics
7.4.1 Polymerase Chain Reaction (PCR)
7.4.2 Isothermal Nucleic Acid Amplification Technology ((INAAT)
7.4.3 Hybridization
7.4.4 DNA Sequencing & Next-Generation Sequencing
7.4.5 Microarrays
7.4.6 Others
7.5 Hematology
7.5.1 Blood Crossmatching
7.5.2 Complete Blood Count (CBC)
7.5.3 Direct Antiglobulin Test (DAT)
7.5.4 Others
7.6 Microbiology
7.7 Coagulation & Hemostasis
7.8 Urinalysis
7.9 Others
8 Global In-Vitro Diagnostics Instruments Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.3 Diabetes
8.4 Oncology
8.5 Cardiology
8.6 Drug Testing/Pharmacogenomics
8.7 HIV/AIDS
8.8 Autoimmune Diseases
8.9 Gynecology
8.10 Nephrology
8.11 Others
9 Global In-Vitro Diagnostics Instruments Market, By End-Users
9.1 Introduction
9.2 Hospital Laboratories
9.3 Clinical Laboratories
9.4 Point-Of-Care Testing
9.5 Self-Testing
9.6 Academic Institutes
9.7 Others
10 Global In-Vitro Diagnostics Instruments Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 South America
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Chile
10.3.4 Colombia
10.4 Europe
10.4.1 UK
10.4.2 France
10.4.3 Germany
10.4.4 Italy
10.4.5 Spain
10.4.6 Netherlands
10.4.7 Sweden
10.4.8 Russia
10.4.9 Rest of Europe
10.5 Asia-Pacific
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 Indonesia
10.5.5 Malaysia
10.5.6 South Korea
10.5.7 Australia
10.5.8 Sri Lanka
10.5.9 Thailand
10.5.10 Rest of APAC
10.6 Middle-East and Africa
10.6.1 Qatar
10.6.2 Saudi Arabia
10.6.3 South Africa
10.6.4 United Arab Emirates
11 Competitive Landscape
11.1 Competitive Quadrant
11.2 Market Share Analysis
11.3 Strategic Initiatives
11.3.1 M&A and Investments
11.3.2 Partnerships and Collaborations
11.3.3 Product Developments and Improvements
12 Company Profiles
12.1 Abbott Laboratories
12.2 bioMérieux
12.3 Illumina
12.4 Ortho Clinical Diagnostics
12.5 Roche Diagnostics
12.6 Siemens Healthineers
12.7 Thermo Fisher Scientific
12.8 Sysmex Corporation
12.9 Fisher Scientific International
12.10 Becton, Dickinson and Company
12.11 Hologic
12.12 Danaher Corporation
12.13 Bio-Rad Laboratories
12.14 Grifols
12.15 Arkray
12.16 Surmodics
12.17 WerfenLife
12.18 PerkinElmer
12.19 DiaSorin
12.20 Qiagen
12.21 Quest Diagnostics
12.22 Quidel Corporation
12.23 Philips Healthcare
12.24 SpeeDx Diagnostics
12.25 GenomeMe
12.26 Aniara Diagnostica
12.27 Charles River Laboratories International
13 Appendix
13.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • bioMérieux
  • Illumina
  • Ortho Clinical Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Fisher Scientific International
  • Becton, Dickinson and Company
  • Hologic
  • Danaher Corporation
  • Bio-Rad Laboratories
  • Grifols
  • Arkray
  • Surmodics
  • WerfenLife
  • PerkinElmer
  • DiaSorin
  • Qiagen
  • Quest Diagnostics
  • Quidel Corporation
  • Philips Healthcare
  • SpeeDx Diagnostics
  • GenomeMe
  • Aniara Diagnostica
  • Charles River Laboratories International